Existing users please login

 

Home / Markets

Wyeth in Talks to Buy Crucell

 
Associated Press
     

    NEW YORK--Dutch vaccine maker Crucell (CRXL) says it is in acquisition talks with drugmaker Wyeth (WYE). Crucell NV says the talks are at preliminary stages.

    The statement comes shortly after a Wall Street Journal report saying Wyeth was in talks to buy Crucell for up to $1.35 billion.

    A spokesman for Madison, New Jersey-based Wyeth says the company does not comment on market speculation.
    The report, published on the newspaper's Web site Wednesday and attributed to unnamed sources, comes hours after Wyeth Chief Executive and Chairman Bernard Poussot told analysts at an investment conference that he believes "the only way forward for the pharmaceutical industry is to get into biotechnology."

     
     

    FOX Translator

    Detach

    No data currently available.

    No data currently available.

    Street Name

    It's time to let you in on a dirty little secret: You may not own the stock you own. That's right, if you invest with a brokerage firm, the shares you bought are almost certainly not held in your name. Technically, they're held in the name of the Wall Street firm you do business with, hence the term "street name."

    No, you haven't been robbed. Ultimately, the decision to hold shares on the books under a different name doesn't affect the economic ramifications for you. You¿re listed as the "beneficial owner," even though the firm is the official owner of the shares. But, you are giving up some rights, and investors concerned about good corporate governance might want to get that stock back in their own names.

    Here's the problem: If your stock is technically owned by, say, Merrill Lynch, then Merrill Lynch gets to do things with it that might work against your wishes. Take short selling. Investors who want to sell shares short need to first borrow those shares. The lenders are often the big Wall Street firms that are handing out Street-name shares. So, if you feel that a company you own is a victim of aggressive short selling, chances are your own shares are being used to fuel the shorting.

    Also, your brokerage firm can cast ballots on some corporate matters affecting a company without getting your input. Technically, this can only happen in votes considered ¿routine¿ by securities regulators. But, there's a big catch: some big events, like board elections, are considered "routine" under law.

    The good news is that you can easily fix the Street name problem: Just request that your brokerage firm makes you the listed owner of the shares. If they refuse, find a new firm.